The interaction between the endocannabinoid and immune system is intricate, and it appears to modulate both innate and adaptive immune responses.

Uwe Blesching, PhD, Co-Founder and Chief Science Officer at CannaKeys, speaks to conference attendees at the WeCann Summit in Campinas, Brazil. Credit: WeCann Academy. Uwe Blesching, PhD, has written ...

In an editorial by Cassandra L. Taylor, PhD, and Schuyler Pruyn, MS, from the US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), the agency looks back on the last 50 ...

In this episode, AJEM talks with Kristel Carrington, MD, an Ivy League-trained psychiatrist, psychotherapist, and psychopharmacologist who specializes in psychedelics. Dr. Carrington is also Chef ...

In this episode, AJEM’s Editor in Chief Leslie Apgar, MD, talks with AJEM Journalist Larry Luxner about their shared experience at the WeCann Summit in Brazil.

Credit: Getty Images. In the past decade, interest in the therapeutic benefits of cannabis has increased, driving an explosion of research to understand better the mechanism of action of cannabis for ...

Credit: Getty Images. When it comes to treating chronic illness, the healthcare industry as a whole is in the process of a paradigm shift away from single molecule therapies and toward combination ...

In this episode, AJEM talks with neurologist Daniel Stein, MD, about cannabis medicine for a variety of neurologic conditions including epilepsy and seizures associated with Lennox-Gastaut syndrome, ...

A prospective, randomized, double-masked, placebo-controlled pilot study explored the effects of adjunctive cannabidiol (CBD) treatment on symptoms associated with blepharospasm (BPS). The study, ...

Oliver Kruze, the 27-year-old CEO of Tikun Olam US, runs the American licensee of Tikun Olam, Israel’s pioneer in medical cannabis research and wellness products. Oliver Kruze, the 27-year-old CEO of ...

In this episode, AJEM speaks with Henrik Jungaberle, Dr. sc. hum., Executive Director of the Berlin, Germany-based MIND Foundation about how psychedelic medicine is finally gaining acceptance in the ...

The amygdala releases its own endocannabinoids (eCBs) to mitigate responses to stress, according to a preclinical study published in Cell Reports. These endogenous cannabinoids interact with the same ...